Clinical and Immunogenetic Features of Recurrent Bronchitis in Children after COVID-19: A Letter to the Editor

This is a preview and has not been published.

Clinical and Immunogenetic Features of Recurrent Bronchitis in Children after COVID-19: A Letter to the Editor

Authors

Abstract

Not applicable

 

Author Biographies

Nozima Sadikova, Tashkent Medical Academy, Tashkent, Uzbekistan,

Nozima Sadikova, MD, PhD, Tashkent Medical Academy, Uzbekistan. Research interests include pediatric respiratory diseases, immunology, and infectious diseases.

Sunnatulla Yulchiev, Independent Research

Sunnatulla Yulchiev, PhD, Independent Researcher, United States. Research interests include respiratory diseases, immunogenetics, and sports medicine.

Ilxamdjan Karimdjanov , Tashkent Medical Academy, Uzbekistan.

Ilxamdjan Karimdjanov, MD, PhD, Professor, Tashkent Medical Academy, Uzbekistan. Research interests include pediatric pulmonology, respiratory diseases, and clinical immunology.

Nargiza Mirsalikhova , Tashkent Medical Academy, Uzbekistan.

Nargiza Mirsalikhova, MD, Tashkent Medical Academy, Uzbekistan. Research interests include pediatric respiratory diseases and clinical practice.

Rano Musazhanova , Tashkent Medical Academy, Uzbekistan.

Rano Musazhanova, MD, Tashkent Medical Academy, Uzbekistan. Research interests include pediatric respiratory diseases and clinical practice.

References

References

1. Saraiva M, O’Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol. 2010;10(3):170-181. https://doi.org/10.1038/nri2711

2. Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A. Interleukin-10 and the interleukin-10receptor. AnnuRev Immunol. 2001;19:683-765. https://doi.org/10.1146/annurev.immunol.19.1.683

3. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24(1):1-8. https://doi.org/10.1111/j.1365-2370.1997.tb00001.x

4. Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033-1034. https://doi.org/doi:10.1016/S0140-6736(20)30628-0

5. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. https://doi:10.1016/S0140-6736(20)30183-5

6. Blanco-Melo D, Nilsson-Payant BE, Liu WC, et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 2020;181(5):1036-1045.e9. https://doi.org/10.1016/j.cell.2020.04.026

How to Cite

1.
Sadikova N, Yulchiev S, Karimdjanov I, Mirsalikhova N, Musazhanova R. Clinical and Immunogenetic Features of Recurrent Bronchitis in Children after COVID-19: A Letter to the Editor. Acta Biomed. 97:18950. doi:10.23750/abm.2026.18950

Issue

Section

LETTERS TO THE EDITOR AND CORRESPONDENCE

How to Cite

1.
Sadikova N, Yulchiev S, Karimdjanov I, Mirsalikhova N, Musazhanova R. Clinical and Immunogenetic Features of Recurrent Bronchitis in Children after COVID-19: A Letter to the Editor. Acta Biomed. 97:18950. doi:10.23750/abm.2026.18950